BOSTON, MA and SAN DIEGO, CA -- (MARKET WIRE) -- July 06, 2006 -- IT&E International Group, Inc. (OTCBB: ITER), a life sciences service organization and full-service clinical research organization (“CRO”), today announced that it has entered into an Agreement and Plan of Merger with privately held Averion Inc., a Massachusetts corporation (“Averion”) and CRO, for the purpose of forming a world-class CRO. The transaction will combine two groups -- IT&E and Millennix, the IT&E division providing comprehensive clinical research services, and Averion -- to form a clinical research organization with unique therapeutic areas of expertise.
